Case Report: Isolated acetabular myeloid sarcoma as the initial presentation of extramedullary blast crisis in chronic myeloid leukemia: a report of two cases and literature review

Read full text
Authors: Cong Wang, Yuanyuan Nie, Qiuju Liu, Yan Jiang, Qiang Guo, Jing Bai, Shanshan Liu, Sujun Gao
Cited by: 0
References: 39

Abstract

Background Myeloid sarcoma (MS) as the initial manifestation of chronic myeloid leukemia (CML), while the bone marrow (BM) remains in the chronic phase, is exceedingly rare. Case presentation We report two cases of MS initially presented with hip pain and soft tissue masses. Both patients had unremarkable complete blood counts and BM morphology, and initial core needle biopsies were misinterpreted as non-Hodgkin lymphoma. Further cytogenetic and molecular analyses, however, identified the Philadelphia chromosome, BCR::ABL rearrangement, and mutations in TP53 , KMT2D and STAG2 , establishing the diagnosis of MS secondary to CML in extramedullary blast phase. Both patients received tyrosine kinase inhibitors with or without chemotherapy, nevertheless, their disease progressed rapidly, resulting in death within one year. Conclusion Through a comprehensive literature review, we identified 33 additional reported cases with the same diagnosis. This disease predominantly affects middle-aged men, with bone and parosteal soft tissues being the most common involved extramedullary site. Such patients may constitute a biologically distinct subgroup and, in some reports, have shown relatively favorable outcomes. However, our cases follow an aggressive clinical course, possibly influenced by high-risk molecular features. Large-scale clinical studies are required to clarify the biological heterogeneity of this subgroup and to optimize therapeutic strategies.

Fields of Study & Subjects

Chronic Myeloid Leukemia Treatments Acute Myeloid Leukemia Research Sarcoma Diagnosis and Treatment

Publication details

Journal / source
Frontiers in Oncology
Volume
16
Pages
1750765–1750765
Publication date
27 February 2026
Language
EN